Picture of Vireo Growth logo

VREO — Vireo Growth News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Vireo Growth Q2 revenue jumps on acquisitions

Vireo Growth Q2 revenue jumps on acquisitions


Overview

  • U.S. cannabis and agribusiness platform's Q2 revenue rose 335% yr/yr, driven by M&A deals

  • Company completed multiple acquisitions in Q2, expanding footprint to new states

  • Announced new asset-based revolving credit facility with $65 mln initial commitment, expandable to $105 mln


Outlook

  • Company expects to remain acquisitive and continue expanding through M&A activity

  • Vireo says integration of recent and pending acquisitions will continue into 2027

  • Company aims to improve profitability and expand free cash flow across core markets


Result Drivers

  • M&A ACTIVITY - Revenue growth attributed to recently closed acquisitions including Hawthorne, Bridgewell, and Eaze

  • PLATFORM DIVERSIFICATION - Expansion into non-cannabis agribusiness segment through Hawthorne and Bridgewell deals

  • STRATEGIC FOCUS - Management emphasized disciplined capital allocation and integration of acquisitions to improve profitability


Company press release: ID:nGNX6CWJzw


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

$209.3 mln

Q2 Gross Profit

$95.3 mln


Reuters Recommended Reads

  • Aug 10 - SHF Holdings Q2 revenue rises 4.8%, net loss widens on deemed dividend

  • Aug 11 - Canada's Organigram Q3 revenue beats on Sanity acquisition; CFO to exit

  • Aug 10 - Flowers Foods seeks to divest Tastykake baked goods business, sources say


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Vireo Growth

See all news